Boston Research & Management’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,375
| Closed | -$202K | – | 118 |
|
|
2025
Q1 | $202K | Hold |
1,375
| – | – | 0.05% | 115 |
|
|
2024
Q4 | $223K | Hold |
1,375
| – | – | 0.05% | 111 |
|
|
2024
Q3 | $224K | Buy |
+1,375
| New | +$204K | 0.05% | 110 |
|
|
2024
Q2 | – | Sell |
-1,375
| Closed | -$210K | – | 114 |
|
|
2024
Q1 | $210K | Buy |
+1,375
| New | +$205K | 0.05% | 115 |
|
|
2023
Q3 | – | Sell |
-1,375
| Closed | -$218K | – | 115 |
|
|
2023
Q2 | $218K | Hold |
1,375
| – | – | 0.06% | 111 |
|
|
2023
Q1 | $217K | Buy |
+1,375
| New | +$206K | 0.06% | 108 |
|
|
2022
Q1 | – | Sell |
-1,375
| Closed | -$239K | – | 112 |
|
|
2021
Q4 | $239K | Hold |
1,375
| – | – | 0.07% | 105 |
|
|
2021
Q3 | $227K | Hold |
1,375
| – | – | 0.07% | 103 |
|
|
2021
Q2 | $247K | Hold |
1,375
| – | – | 0.07% | 102 |
|
|
2021
Q1 | $265K | Hold |
1,375
| – | – | 0.09% | 96 |
|
|
2020
Q4 | $277K | Hold |
1,375
| – | – | 0.1% | 93 |
|
|
2020
Q3 | $288K | Hold |
1,375
| – | – | 0.11% | 88 |
|
|
2020
Q2 | $301K | Hold |
1,375
| – | – | 0.13% | 85 |
|
|
2020
Q1 | $238K | Hold |
1,375
| – | – | 0.12% | 85 |
|
|
2019
Q4 | $211K | Hold |
1,375
| – | – | 0.08% | 100 |
|
|
2019
Q3 | $208K | Hold |
1,375
| – | – | 0.08% | 98 |
|
|
2019
Q2 | $210K | Hold |
1,375
| – | – | 0.08% | 98 |
|
|
2019
Q1 | $220K | Hold |
1,375
| – | – | 0.09% | 100 |
|
|
2018
Q4 | $211K | Hold |
1,375
| – | – | 0.1% | 95 |
|
|
2018
Q3 | $206K | Buy |
+1,375
| New | +$195K | 0.09% | 99 |
|
|
2018
Q2 | – | Sell |
-1,595
| Closed | -$212K | – | 98 |
|
|
2018
Q1 | $212K | Hold |
1,595
| – | – | 0.11% | 94 |
|
|
2017
Q4 | $237K | Hold |
1,595
| – | – | 0.12% | 89 |
|
|
2017
Q3 | $210K | Hold |
1,595
| – | – | 0.11% | 95 |
|
|
2017
Q2 | $212K | Hold |
1,595
| – | – | 0.11% | 93 |
|
|
2017
Q1 | $215K | Buy |
+1,595
| New | +$207K | 0.12% | 92 |
|
|
2016
Q3 | – | Sell |
-1,530
| Closed | -$211K | – | 94 |
|
|
2016
Q2 | $211K | Buy |
+1,530
| New | +$198K | 0.13% | 95 |
|
|
2016
Q1 | – | Sell |
-14,818
| Closed | -$1.88M | – | 96 |
|
|
2015
Q4 | $1.88M | Hold |
14,818
| – | – | 1.17% | 40 |
|
|
2015
Q3 | $1.71M | Sell |
14,818
-20
| -0.1% | -$2.25K | 1.13% | 42 |
|
|
2015
Q2 | $1.54M | Sell |
14,838
-290
| -2% | -$31.3K | 0.98% | 47 |
|
|
2015
Q1 | $1.67M | Sell |
15,128
-10,570
| -41% | -$1.15M | 1.06% | 43 |
|
|
2014
Q4 | $2.68M | Sell |
25,698
-220
| -0.8% | -$22K | 1.68% | 23 |
|
|
2014
Q3 | $2.49M | Sell |
25,918
-485
| -2% | -$43.9K | 1.67% | 21 |
|
|
2014
Q2 | $2.41M | Sell |
26,403
-880
| -3% | -$78.8K | 1.67% | 20 |
|
|
2014
Q1 | $2.4M | Buy |
27,283
+1,710
| +7% | +$150K | 1.77% | 20 |
|
|
2013
Q4 | $2.37M | Sell |
25,573
-182
| -0.7% | -$16.4K | 1.82% | 17 |
|
|
2013
Q3 | $2.1M | Sell |
25,755
-25
| -0.1% | -$2.11K | 1.78% | 22 |
|
|
2013
Q2 | $2.14M | Buy |
+25,780
| New | +$2.22M | 1.91% | 18 |
|
Other funds holding CLX
Boston Research & Management's CLX Position: Q2 2025 in Review
Boston Research & Management sold out of Clorox (CLX) in Q2 2025, closing a stake of 1,375 shares — an estimated $202K sold.
Boston Research & Management first reported a position in CLX in Q2 2013 and held it in 37 quarters. The position peaked at $2.68M in Q4 2014. 1,125 funds tracked by Wall St. Rank hold CLX as of Q2 2025.
- Boston Research & Management reported no remaining Clorox position as of Q2 2025 after selling out during the quarter.
- Boston Research & Management sold 1,375 Clorox shares in Q2 2025, an estimated $202K.
- Boston Research & Management first reported a position in Clorox in Q2 2013 and held it in 37 quarters.
- Boston Research & Management's Clorox position peaked at $2.68M in Q4 2014.
- 1,125 funds tracked by Wall St. Rank held Clorox as of Q2 2025.
Based on Boston Research & Management's 13F filing for Q2 2025, filed 12 Aug 2025.